World
Brazil regulator says Bharat Biotech vaccine does not meet factory standards
- The Brazilian government signed a contract last month to buy 20 million doses of the Indian drugmaker's vaccine. Bharat Biotech applied for emergency use of the vaccine in Brazil on March 8.
1 min
By
SAO PAULO: Brazilian health regulator Anvisa said Bharat Biotech's Covaxin COVID-19 does not meet its manufacturing standards, according to a note in the Tuesday edition of the official gazette.
The Brazilian government signed a contract last month to buy 20 million doses of the Indian drugmaker's vaccine. Bharat Biotech applied for emergency use of the vaccine in Brazil on March 8.